drugset / Trial / NCT01404091
A Study of Nociceptin/Orphanin FQ Peptide Receptor Occupancy in Healthy Subjects
Non-randomizedSingle-groupOpen-labelOther
Summary
The purpose of this trial is to conduct an assessment of brain nociceptin/orphanin FQ peptide (NOP) receptor occupancy (RO) in healthy subjects.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2940094 | Small molecule | 4 mg | Oral |
| Subject | LY2940094 | Small molecule | 10 mg | Oral |
| Subject | LY2940094 | Small molecule | 20 mg | Oral |
| Subject | LY2940094 | Small molecule | 40 mg | Oral |